tci Medicare Compliance & Reimbursement - 2005 Issue 16
PHARMACEUTICALS: Medicare Slashes Drugs By Up To 60 Percent
But some drugs may actually get a payment bump.Any providers pining for Medicare payments for Part B drugs to stop plummeting could have a major shock in store.The Centers for Medicare and Medicaid Services issued the updated drug reimbursements that take effect April 1, 2005, and some drugs face sharp declines. Carboplatin Payouts Down Drastically For example, the payment for carboplatin (J9045) drops 39.6 percent, from $125.47 currently to $75.75 in the second quarter, according to an analysis released by the American Society of Clinical Oncology.Other drugs face steep payment declines as well...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.